Defendant Singh Raghvendra Pratar, an executive of Quramax Medical, is among the 23 people jailed (Picture: Reuters)
A six-month long trial over a cough syrup linked to the deaths of 68 children has finally ended, bringing some closure to their heartbroken families.
Parents of the victims affected by the drug will receive a compensation of £63,000.
As many as 23 people have also been jailed today over the tragedy that engulfed Uzbekistan in 2022.
The scandal broke out over the Doc-1 Max medicine by the Indian pharmaceutical company Marion Biotech.
The Central Asian nation had previously reported that 65 children had died afterdrinking the medicines, but last month the prosecutors at the Tashkent city court updated the death toll.
Prosecutors added that two more people had been charged during the hearings.
The Doc-1 Max medicine was pulled out from the shelves
The defendants, including one Indian national, faced jail terms ranging from two to 20 years.
They were found guilty of tax evasion, sale of substandard or counterfeit drugs, abuse of office, negligence, forgery, and bribery.
Singh Raghvendra Pratar, an executive director of Quramax Medical, the company that sold medicines produced by India’s Marion Biotech, was handed the longest – a 20-year prison term.
Former senior officials who were in charge of licensing imported medicines were also sentenced to lengthy terms.
The court ruled that compensation amounting to £63,000 (1 billion Uzbek sums) would be paid to each of the families of 68 children who died from consumption of the syrup, as well as to four other children who became disabled.
Parents of eight other children affected by the medicine will get from £12,000 to £31,000.
The compensation money will be collected from seven of the convicts, the court’s decision said, according to the Supreme Court statement.
This is a developing news story, more to follow soon… Check back shortly for further updates.
Got a story? Get in touch with our news team by emailing us at webnews@metro.co.uk. Or you can submit your videos and pictures here.
For more stories like this, check our news page.
Follow Metro.co.uk on Twitter and Facebook for the latest news updates. You can now also get Metro.co.uk articles sent straight to your device. Sign up for our daily push alerts here.